Real-Time and Retrospective Emotion Awareness With Cognitive Reappraisal Training
21 maggio 2026 aggiornato da: Asia University
Real-Time and Retrospective Emotion Awareness With Cognitive Reappraisal: Effects on Anxious-Depressive Symptoms and Well-Being
This pilot randomized active-comparison study examined two formats of emotional awareness and cognitive reappraisal training for adults with co-occurring anxiety and depressive symptoms.
Participants were assigned to either a real-time awareness group or a retrospective awareness group.
The real-time awareness group used a smartwatch-based heart-rate prompting system to identify emotions in daily life and later complete cognitive reappraisal exercises.
The retrospective awareness group completed daily evening reflection and cognitive reappraisal exercises based on emotional events from that day.
The study lasted six weeks and included assessments at baseline, mid-intervention, and post-intervention.
Outcomes included anxiety symptoms, depressive symptoms, emotional clarity, mood repair, cognitive reappraisal, expressive suppression, and psychological well-being.
The purpose of the study was to examine preliminary patterns of change and compare how the two formats may support emotion regulation processes.
Panoramica dello studio
Stato
Completato
Descrizione dettagliata
The study used a pilot randomized active-comparison design. Participants were adults aged 18 to 45 years with co-occurring anxiety and depressive symptoms. Eligible participants were randomly assigned to one of two intervention conditions: a real-time awareness condition or a retrospective awareness condition. The intervention lasted six weeks and included three assessment points: baseline/pretest, mid-intervention assessment, and post-intervention assessment.
The intervention consisted of two sequential phases. The first phase lasted approximately two weeks and focused on heart-rate baseline collection and emotional awareness training. Participants in the real-time awareness condition wore a smartwatch for three consecutive days to establish an individualized heart-rate baseline, followed by eleven days of real-time emotion identification training triggered by physiological prompts. When heart rate exceeded the individualized threshold, participants received a vibration prompt and selected the emotion category that best represented their current state. Participants in the retrospective awareness condition received no active intervention during this initial phase.
The second phase consisted of four weeks of cognitive reappraisal training for both groups. The reappraisal training was based on psychological distancing, particularly self-distancing and third-person perspective taking. During this phase, participants in the real-time awareness condition continued to receive physiological prompts and completed cognitive reappraisal exercises immediately after these prompts. Participants in the retrospective awareness condition completed daily evening reappraisal exercises based on emotionally salient events recalled from that day. Both groups attended weekly meetings with the researcher to review strategy use and discuss difficulties encountered during implementation.
Self-report outcomes were assessed at baseline, mid-intervention, and post-intervention. The study examined changes in anxiety symptoms, depressive symptoms, emotional clarity, mood repair, cognitive reappraisal, expressive suppression, and psychological well-being. The primary purpose was to characterize feasibility, preliminary effects, and temporal patterns of change associated with the two intervention formats rather than to establish definitive treatment efficacy.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
42
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
-
Taichung, Taiwan, 41354
- 亞洲大學
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
No
Descrizione
Inclusion Criteria:
- Adults aged 18 to 45 years.
- Self-reported co-occurring anxiety and depressive symptoms.
- Score of 8 or above on the Chinese version of the Beck Anxiety Inventory.
- Score between 14 and 28 on the Chinese version of the Beck Depression Inventory-II.
- Ability to provide written informed consent and complete the study procedures.
Exclusion Criteria:
- Illegal substance use.
- Excessive alcohol or caffeine consumption, defined as more than four caffeinated beverages or four cans of beer per day.
- Major psychiatric disorders or cognitive impairment, such as schizophrenia or neurocognitive disorders.
- Current psychiatric medication use.
- Ongoing psychological or psychiatric treatment.
- Pregnancy or current responsibility for caring for an infant.
- Severe depressive symptoms, defined as a Beck Depression Inventory-II score of 29 or above.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Real-Time Awareness With Cognitive Reappraisal
Participants in this arm wore a smartwatch to establish an individualized heart-rate baseline and subsequently received vibration prompts when heart rate exceeded the individualized threshold.
During the emotional awareness phase, participants identified their current emotional state following physiological prompts.
During the cognitive reappraisal phase, participants completed a third-person perspective-taking reappraisal exercise immediately after physiological prompts.
|
This behavioral intervention combined wearable-based physiological prompting, real-time emotion identification, and third-person cognitive reappraisal.
Participants wore a smartwatch that monitored heart rate continuously.
When heart rate exceeded 20% above the individualized baseline, the device delivered a vibration prompt.
Participants identified their current emotion from six basic emotion categories.
During the reappraisal phase, they recorded the triggering event, emotion category, emotional intensity, and thoughts, and then completed a third-person perspective-taking reappraisal exercise.
|
|
Comparatore attivo: Retrospective Awareness With Cognitive Reappraisal
Participants in this arm received no active intervention during the initial awareness phase.
During the cognitive reappraisal phase, participants completed a daily evening reappraisal exercise based on an emotionally salient event from that day.
They recorded the emotion category, emotional intensity, and thoughts experienced at the time of the event, then completed the same third-person perspective-taking reappraisal exercise as the real-time awareness group.
|
This behavioral intervention combined daily end-of-day emotional reflection with third-person cognitive reappraisal.
Participants recalled an emotionally salient event from that day, recorded the emotion category, emotional intensity, and thoughts experienced at the time of the event, and then reinterpreted the event from the perspective of a personally significant or neutral third-person figure.
They subsequently reported their post-reappraisal emotion category, emotional intensity, and new thoughts.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Anxiety Symptoms
Lasso di tempo: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Anxiety symptoms were assessed using the Chinese version of the Beck Anxiety Inventory (BAI).
The BAI consists of 21 items rated on a 4-point scale from 0 to 3, with total scores ranging from 0 to 63.
Higher scores indicate greater anxiety symptom severity.
|
Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
|
Change in Depressive Symptoms
Lasso di tempo: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Depressive symptoms were assessed using the Chinese version of the Beck Depression Inventory-II (BDI-II).
The BDI-II consists of 21 items rated on a 4-point scale from 0 to 3, with total scores ranging from 0 to 63.
Higher scores indicate greater depressive symptom severity.
|
Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Emotional Clarity
Lasso di tempo: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Emotional clarity was assessed using the emotional clarity subscale of the Chinese version of the Trait Meta-Mood Scale (TMMS).
Higher scores indicate greater perceived ability to identify and understand one's emotions.
|
Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
|
Change in Mood Repair
Lasso di tempo: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Mood repair was assessed using the mood repair subscale of the Chinese version of the Trait Meta-Mood Scale (TMMS).
Higher scores indicate stronger perceived ability to regulate, alleviate, or repair negative emotional states.
|
Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
|
Change in Cognitive Reappraisal
Lasso di tempo: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Cognitive reappraisal was assessed using the cognitive reappraisal subscale of the Chinese version of the Emotion Regulation Questionnaire (ERQ).
Higher scores indicate greater habitual use of cognitive reappraisal.
|
Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
|
Change in Expressive Suppression
Lasso di tempo: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Expressive suppression was assessed using the expressive suppression subscale of the Chinese version of the Emotion Regulation Questionnaire (ERQ).
Higher scores indicate greater habitual use of expressive suppression.
|
Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
|
Change in Psychological Well-Being
Lasso di tempo: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Psychological well-being was assessed using the psychological well-being subscale of the Taiwan Subjective Well-Being Scale Short-Form (TSWBS-SF).
The subscale consists of 4 items rated on a 4-point Likert scale, with total scores ranging from 4 to 16.
Higher scores indicate greater psychological well-being.
|
Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Han-Yun Chang, Ph.D., Asia University
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
25 gennaio 2024
Completamento primario (Effettivo)
20 giugno 2024
Completamento dello studio (Effettivo)
20 giugno 2024
Date di iscrizione allo studio
Primo inviato
21 maggio 2026
Primo inviato che soddisfa i criteri di controllo qualità
21 maggio 2026
Primo Inserito (Effettivo)
26 maggio 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
26 maggio 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
21 maggio 2026
Ultimo verificato
1 maggio 2026
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CRREC-112-036
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
SÌ
Descrizione del piano IPD
De-identified individual participant data and analytic code may be available from the authors upon reasonable request, subject to ethical approval and participant confidentiality restrictions.
Periodo di condivisione IPD
De-identified individual participant data and analytic code will be available after publication and for five years.
Criteri di accesso alla condivisione IPD
De-identified individual participant data and analytic code may be shared with qualified researchers for research purposes upon reasonable request.
Requests will be reviewed by the study team and will require appropriate ethical approval, a data-sharing agreement when applicable, and compliance with participant confidentiality restrictions.
Tipo di informazioni di supporto alla condivisione IPD
- CODICE_ANALITICO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .